Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
Authors
Keywords
Stenosis, Coronary heart disease, Fibroblast growth factor, Cholesterol, Coronary arteries, Angiography, Coronary revascularization, Diabetes mellitus
Journal
PLoS One
Volume 8, Issue 8, Pages e72545
Publisher
Public Library of Science (PLoS)
Online
2013-08-29
DOI
10.1371/journal.pone.0072545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Coronary angiographic scoring systems: An evaluation of their equivalence and validity
- (2012) Ian J. Neeland et al. AMERICAN HEART JOURNAL
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis
- (2012) Yu Kataoka et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fibroblast growth factor 23: state of the field and future directions
- (2012) Nisan Bhattacharyya et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
- (2011) Eric N. Taylor et al. AMERICAN HEART JOURNAL
- Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women
- (2011) Mansi Dalal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease
- (2011) Suetonia C. Palmer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
- (2011) M. Wolf et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
- (2011) L. Desjardins et al. OSTEOPOROSIS INTERNATIONAL
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function
- (2007) Marcel Roos et al. CLINICAL ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More